Description: Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, isobaric reagents, and biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes. It primarily serves pharmaceutical companies and other sectors, including academic research. The company was incorporated in 1993 and is headquartered in London, the United Kingdom.
Home Page: www.proteomics.com
Coveham House
Cobham,
KT11 3EP
United Kingdom
Phone:
44 20 7043 2116
Officers
| Name | Title |
|---|---|
| Dr. Mariola Sohngen | CEO & Exec. Director |
| Dr. Ian H. Pike | Chief Scientific Officer & Exec. Director |
| Mr. Richard Paul Dennis | Chief Commercial Officer & Exec. Director |
| Mr. Abdelghani Omari | CFO & Director |
| Mr. Glenn Barney | VP of Sales & Marketing |
| Victoria Birse | Company Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 2.313 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 27 |